The dopamine transporter: importance in Parkinson's disease (Q44918547)

7 December 2017

The dopamine transporter: importance in Parkinson's disease (English)

1 reference

7 December 2017

0 references

1 reference

1

John G Nutt

1 reference

7 December 2017

Julie H Carter

2

1 reference

PubMed ID

15174010

7 December 2017

Gary J Sexton

series ordinal

3

1 reference

7 December 2017

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

55

1 reference

7 December 2017

766-773

1 reference

7 December 2017

6

1 reference

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

7 December 2017

1 reference

SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD

21 January 2018

1 reference

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.

21 January 2018

1 reference

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.

21 January 2018

1 reference

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.20089

1 reference

7 December 2017

1 reference

PubMed ID

15174010